TY - JOUR
T1 - Contact Dermatitis Associated with Nail Care Products
T2 - Retrospective Analysis of North American Contact Dermatitis Group Data, 2001-2016
AU - Warshaw, Erin M.
AU - Voller, Lindsey M.
AU - Silverberg, Jonathan I.
AU - Dekoven, Joel G.
AU - Atwater, Amber R.
AU - Maibach, Howard I.
AU - Reeder, Margo J.
AU - Sasseville, Denis
AU - Belsito, Donald V.
AU - Deleo, Vincent A.
AU - Fransway, Anthony F.
AU - Fowler, Joseph F.
AU - Taylor, James S.
AU - Pratt, Melanie D.
AU - Mathias, Toby
AU - Marks, James G.
AU - Zug, Kathryn A.
AU - Zirwas, Matthew J.
N1 - Publisher Copyright:
© Lippincott Williams & Wilkins.
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Background Ingredients in nail care products may lead to allergic and/or irritant contact dermatitis. Objective The aims of this study were to determine frequency of contact dermatitis associated with nail care products, characterize associated body sites, and describe causative allergens. Methods A retrospective analysis was conducted with the North American Contact Dermatitis Group data between 2001 and 2016. Results Of the 38,775 patients tested, 769 (2.0%) had: 1) more than 1 allergic patch test reaction associated with a nail care product (n = 746), 2) irritant contact dermatitis associated with a nail care product (n = 14), or 3) both (n = 9). Primary body sites included the face (43.0%) and hands (27.6%). The top 5 allergens were (2-hydroxyethyl methacrylate (273/482, 56.6%), methyl methacrylate (210/755, 27.8%), ethyl acrylate (190/755, 25.2%), ethyl-2-cyanoacrylate (12/175, 6.9%) and tosylamide (273/755, 36.2%). Frequency of allergy to 2-hydroxyethyl methacrylate (P = 0.0069) and ethyl acrylate (P = 0.0024) significantly increased over the study period, whereas allergy secondary to tosylamide significantly decreased (P < 0.0001). Conclusions As long-lasting nail techniques become widespread, the prevalence of contact dermatitis to nail care products is expected to increase. Almost one-fifth of nail care product-associated allergens would have been missed without additional screening allergens beyond the North American Contact Dermatitis Group series, underscoring the need for testing to a broad array of allergens.
AB - Background Ingredients in nail care products may lead to allergic and/or irritant contact dermatitis. Objective The aims of this study were to determine frequency of contact dermatitis associated with nail care products, characterize associated body sites, and describe causative allergens. Methods A retrospective analysis was conducted with the North American Contact Dermatitis Group data between 2001 and 2016. Results Of the 38,775 patients tested, 769 (2.0%) had: 1) more than 1 allergic patch test reaction associated with a nail care product (n = 746), 2) irritant contact dermatitis associated with a nail care product (n = 14), or 3) both (n = 9). Primary body sites included the face (43.0%) and hands (27.6%). The top 5 allergens were (2-hydroxyethyl methacrylate (273/482, 56.6%), methyl methacrylate (210/755, 27.8%), ethyl acrylate (190/755, 25.2%), ethyl-2-cyanoacrylate (12/175, 6.9%) and tosylamide (273/755, 36.2%). Frequency of allergy to 2-hydroxyethyl methacrylate (P = 0.0069) and ethyl acrylate (P = 0.0024) significantly increased over the study period, whereas allergy secondary to tosylamide significantly decreased (P < 0.0001). Conclusions As long-lasting nail techniques become widespread, the prevalence of contact dermatitis to nail care products is expected to increase. Almost one-fifth of nail care product-associated allergens would have been missed without additional screening allergens beyond the North American Contact Dermatitis Group series, underscoring the need for testing to a broad array of allergens.
UR - http://www.scopus.com/inward/record.url?scp=85084626849&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084626849&partnerID=8YFLogxK
U2 - 10.1097/DER.0000000000000583
DO - 10.1097/DER.0000000000000583
M3 - Article
C2 - 32355091
AN - SCOPUS:85084626849
SN - 1710-3568
VL - 31
SP - 191
EP - 201
JO - Dermatitis
JF - Dermatitis
IS - 3
ER -